VEGFA and myocardial infarction: The present study found that DAPT therapy could reduce pathological damage from myocardial infarction in rats and effectively inhibit platelet activation, but also that DAPT damages gastric mucosa by inhibiting the expression of COX-1, COX-2, PGE2, PGI2, and VEGF.